CONFUNDUS 25MG/250MG TABLETS (CARBIDOPA 25MG + LEVODOPA 250MG)

TZS 18,000

In stock

CONFUNDUS TABLETS CONTAIN CARBIDOPA 25MG AND LEVODOPA 250MG, A COMBINATION MEDICATION USED IN THE MANAGEMENT OF PARKINSON'S DISEASE AND CERTAIN PARKINSONIAN SYNDROMES. LEVODOPA IS CONVERTED INTO DOPAMINE IN THE BRAIN, HELPING REPLACE REDUCED DOPAMINE LEVELS ASSOCIATED WITH PARKINSON'S DISEASE. CARBIDOPA PREVENTS THE PREMATURE BREAKDOWN OF LEVODOPA OUTSIDE THE BRAIN, ALLOWING MORE LEVODOPA TO REACH THE CENTRAL NERVOUS SYSTEM WHILE REDUCING CERTAIN PERIPHERAL SIDE EFFECTS. THE COMBINATION HELPS IMPROVE MOVEMENT, REDUCE MUSCLE STIFFNESS, CONTROL TREMORS AND MANAGE SLOWNESS OF MOVEMENT.